跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70,234 条关于
“Diabetic Peripheral Neuropathic Pain”
全部
70,234
临床试验
64,045
药物
570
机构
136
资讯
5,483
去年
Lexicon Pharmaceuticals Presents Patient-Reported Data on Diabetic Peripheral Neuropathic Pain at ASPN 2025
去年
Lexicon to Host Expert Panel on LX9211, Novel Non-Opioid Treatment for Diabetic Neuropathic Pain
去年
Lexicon's LX9211 Shows Promise for Diabetic Neuropathic Pain, Sotagliflozin Demonstrates Cardiovascular Benefits
去年
Lexicon Pharmaceuticals Completes Enrollment for Phase IIb Trial of LX9211 in Diabetic Peripheral Neuropathic Pain
去年
FDA Halts Rapport Therapeutics' RAP-219 Trial for Diabetic Neuropathic Pain
10个月前
Lilly Discontinues P2X7 Inhibitor LY3857210 for Chronic Pain After Phase II Failure
去年
Lexicon's LX9211 Phase 2b Trial for Diabetic Neuropathic Pain Completes Screening Ahead of Schedule
去年
Lexicon Pharmaceuticals Restructures, Cuts 60% of Staff After FDA Flags Zynquista Deficiencies
去年
FDA Updates: Clinical Hold on Rapport's RAP-219 for DPNP, Phase 2 Trial for Mivelsiran in CAA, and Review of Ataluren Resubmission
去年
Biogen Secures $250M from Royalty Pharma to Advance Lupus Antibody into Phase III Trials
第 1 页，共 549 页
上一页
下一页
